Other News

BioMed Alliance creates Permanent Committee on Continuing Medical Education

EBRA, European Brain Research Area

TO: WHO Director-General Dr Tedros Adhanom Ghebreyesus Epilepsy is the most common and potentially devastating chronic neurological disease that affects people across the lifespan. In Europe, epilepsy affects 6 million people (prevalence 8/1000) and the lifetime cumulative prevalence of epilepsy… Continue Reading

  This year, the EANM Focus Meeting is entitled “Molecular Imaging of Dementia – The Future is Here”. It will take place in the end of January 2019 in Cannes, France.   The meeting will be devoted to the latest… Continue Reading

The award was introduced by Dystonia Europe in 2003 and is presented every two years to stimulate research on dystonia, especially by young scientists in Europe.

Health research in Europe needs and inclusive and long term policy to achieve better health and wellbeing of citizens and to create societal and economic value for Europe.

The Third High-Level Meeting of the United Nations on Non-Communicable Diseases – Time to deliver leaving no one behind and Report on the 68th Session of the WHO Regional Committee for Europe

by Anna Sauerbier

EFNA is focusing attention on young neurology patients during 2018. Their goal is to create a programme that assists young people in becoming advocates for their own disease areas.

The European Parliament Interest Group on Mental health, Well-being and Brain Disorders (with co-hosting MEPs Tomas Zdechovsky and Nessa Childers), EBC, GAMIAN-Europe, the European Psychiatric Association (EPA), EUFAMI, the Expert Platform on Depression, Eurocarers, the European College of Neuropsychopharmacology (ECNP), the UEMS – Sector of Psychiatry and the International Federation for Psychotherapy have launched a joint policy paper on major depression, entitled ‘A sustainable approach to depression: moving from words to actions’, at the European Parliament in Brussels.

Reference Networks: A second opinion - How EU networks share knowledge to save lives

As 2018 draws to a close, the Social Impact of Pain (SIP) initiative can be proud of its achievements in the past 12 months.

The African Academy of Neurology (AFAN) was created in August 2015 under the aegis of the WFN to be the African regional representative body for all that relates to neurology and allied fields. AFAN collaborates actively with other international organisations; the WFN, EAN, AAN, and MDS amongst others, to achieve the goals of AFAN and its member states. These international-organisations have been invaluable in their support; financially, logistically and by sharing expertise. AFAN is still in its fledgling state and relies greatly on its international partners. With passing years, as we gain experience and become stronger, we hope to reach our place on the international neurological stage as equal partners in the theatre of neurological disease.

4 December 2018: Alzheimer Europe’s European Parliament lunch debate focuses on Dementia as a priority of the EU health programme Alzheimer Europe held its final lunch debate of 2018 in the European parliament on 4 December 2018. The debate focused on the topic of “Dementia as a priority of the EU health programme”.

Today is the last day of our EAN Holiday Countdown – we thank everyone who have participated in our raffles and contacted us regarding our articles. We hope you all had a lovely holiday season and now get to relax… Continue Reading